In conclusion, we show hyperinflammation characterized by significantly increased cytokine and chemokine levels, hyperactivated neutrophils, and elevated levels of protease inhibitors TIMP-1, SLPI, and elafin in the lungs of critically ill COVID-19 patients in comparison with influenza patients. Here, SLPI is linked to COVID-19.